Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● The company is in a robust financial situation considering its net cash and margin position.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The opinion of analysts covering the stock has improved over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The firm trades with high earnings multiples: 25.53 times its 2023 earnings per share.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.